Chronic Lymphocytic Leukemia medications
In this page you will find the list of drugs approved by the FDA to treat Chronic Lymphocytic Leukemia.
acalabrutinib (Calquence)
Tyrosine Kinase Inhibitors
Learn More arrow_right_alt
alemtuzumab (Campath)
Monoclonal Antibodies
Learn More arrow_right_alt
Chlorambucil (Leukeran)
Chemotherapy Agents
Learn More arrow_right_alt
cladribine (Leustatin)
Chemotherapy Agents
Learn More arrow_right_alt
dexamethasone (Decadron)
Systemic Steroids
Learn More arrow_right_alt
duvelisib (Copiktra)
Targeted Therapies
Learn More arrow_right_alt
ibrutinib (Imbruvica)
Tyrosine Kinase Inhibitors
Learn More arrow_right_alt
idelalisib (Zydelig)
Targeted Therapies
Learn More arrow_right_alt
lenalidomide (Revlimid)
Immunomodulatory Agents
Learn More arrow_right_alt
obinutuzumab (Gazyva)
Monoclonal Antibodies
Learn More arrow_right_alt
ofatumumab (Arzerra)
Monoclonal Antibodies
Learn More arrow_right_alt
pentostatin (Nipent)
Chemotherapy Agents
Learn More arrow_right_alt
pirtobrutinib (Jaypirca)
Tyrosine Kinase Inhibitors
Learn More arrow_right_alt
rituximab (Riabni, Rituxan, Ruxience, Truxima)
Monoclonal Antibodies
Learn More arrow_right_alt
venetoclax (Venclexta)
Targeted Therapies
Learn More arrow_right_alt
Together we care.
Together we cure.
3x Faster.
Join our year-end match and help us reach $2 million for blood cancer research!